PotentandselectiveP2Y12receptorantagonist.BlocksADP-inducedinhibitionofadenylylcyclaseinvitro(pKB=7.6)andinhibitsADP-inducedaggregationofwashedhumanplatelets(pIC50=8.16).
SoldforresearchpurposesunderagreementfromAstraZeneca
M.Wt | 703.26 |
Formula | C14H18F2N5Na4O12P3S |
Storage | Storeat-20°C |
Purity | ≥98%(HPLC) |
CASNumber | 145782-74-7 |
PubChemID | 90488830 |
InChIKey | IETVOLFQZIGNAQ-HVYRMSERSA-J |
Smiles | [Na+].[Na+].[Na+].[Na+].CCCSC1=NC(N)=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP([O-])(=O)C(F)(F)P([O-])([O-])=O)[C@@H](O)[C@H]3O)C2=N1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Solubility | Solubleinwater(suppliedpre-dissolvedataconcentrationof10mM) |
Thefollowingdataisbasedontheproductmolecularweight703.26.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 1.42mL | 7.11mL | 14.22mL |
5mM | 0.28mL | 1.42mL | 2.84mL |
10mM | 0.14mL | 0.71mL | 1.42mL |
50mM | 0.03mL | 0.14mL | 0.28mL |